Heterogeneity of lung disease associated with NK2 homeobox 1 mutations

Whitsett, 2015, Diseases of pulmonary surfactant homeostasis, Annu. Rev. Pathol., 10, 371, 10.1146/annurev-pathol-012513-104644 Nathan, 2012, A national internet-linked based database for pediatric interstitial lung diseases: the French network, Orphanet J. Rare Dis., 7, 40, 10.1186/1750-1172-7-40 Weaver, 2001, Function of surfactant proteins B and C, Annu. Rev. Physiol., 63, 555, 10.1146/annurev.physiol.63.1.555 Wert, 2009, Genetic disorders of surfactant dysfunction, Pediatr. Dev. Pathol., 12, 253, 10.2350/09-01-0586.1 Perez-Gil, 2008, Structure of pulmonary surfactant membranes and films: the role of proteins and lipid-protein interactions, Biochim. Biophys. Acta, 1778, 1676, 10.1016/j.bbamem.2008.05.003 Hamdan, 1998, Structure of the human Nkx2.1 gene, Biochim. Biophys. Acta, 1396, 336, 10.1016/S0167-4781(97)00210-8 Trueba, 2005, PAX8, TITF1, and FOXE1 gene expression patterns during human development: new insights into human thyroid development and thyroid dysgenesis-associated malformations, J. Clin. Endocrinol. Metab., 90, 455, 10.1210/jc.2004-1358 Guazzi, 1990, Thyroid nuclear factor 1 (TTF-1) contains a homeodomain and displays a novel DNA binding specificity, EMBO J., 9, 3631, 10.1002/j.1460-2075.1990.tb07574.x Kimura, 1996, The T/ebp null mouse: thyroid-specific enhancer-binding protein is essential for the organogenesis of the thyroid, lung, ventral forebrain, and pituitary, Genes Dev., 10, 60, 10.1101/gad.10.1.60 Carre, 2009, Five new TTF1/NKX2.1 mutations in brain-lung-thyroid syndrome: rescue by PAX8 synergism in one case, Hum. Mol. Genet., 18, 2266, 10.1093/hmg/ddp162 Hamvas, 2013, Heterogeneous pulmonary phenotypes associated with mutations in the thyroid transcription factor gene NKX2-1, Chest, 144, 794, 10.1378/chest.12-2502 Bush, 2015, European protocols for the diagnosis and initial treatment of interstitial lung disease in children, Thorax, 70, 1078, 10.1136/thoraxjnl-2015-207349 Jovien, 2016, Respiratory distress, congenital hypothyroidism and hypotonia in a newborn, Respiration, 92, 188, 10.1159/000449136 Guillot, 2010, NKX2-1 mutations leading to surfactant protein promoter dysregulation cause interstitial lung disease in “Brain-Lung-Thyroid Syndrome”, Hum. Mutat., 31, E1146, 10.1002/humu.21183 Gras, 2012, Benign hereditary chorea: phenotype, prognosis, therapeutic outcome and long term follow-up in a large series with new mutations in the TITF1/NKX2-1 gene, J. Neurol. Neurosurg. Psychiatry, 83, 956, 10.1136/jnnp-2012-302505 Thorwarth, 2014, Comprehensive genotyping and clinical characterisation reveal 27 novel NKX2-1 mutations and expand the phenotypic spectrum, J. Med. Genet., 51, 375, 10.1136/jmedgenet-2013-102248 Asmus, 2005, A novel TITF-1 mutation causes benign hereditary chorea with response to levodopa, Neurology, 64, 1952, 10.1212/01.WNL.0000164000.75046.CC Pohlenz, 2002, Partial deficiency of thyroid transcription factor 1 produces predominantly neurological defects in humans and mice, J. Clin. Invest, 109, 469, 10.1172/JCI0214192 Ferrara, 2008, A novel NKX2.1 mutation in a family with hypothyroidism and benign hereditary chorea, Thyroid, 18, 1005, 10.1089/thy.2008.0085 Willemsen, 2005, Brain-Thyroid-Lung syndrome: a patient with a severe multi-system disorder due to a de novo mutation in the thyroid transcription factor 1 gene, Eur. J. Pediatr., 164, 28, 10.1007/s00431-004-1559-x Peall, 2014, Benign hereditary chorea related to NKX2.1: expansion of the genotypic and phenotypic spectrum, Dev. Med. Child. Neurol., 56, 642, 10.1111/dmcn.12323 Salerno, 2014, Respiratory insufficiency in a newborn with congenital hypothyroidism due to a new mutation of TTF-1/NKX2.1 gene, Pediatr. Pulmonol., 49, E42, 10.1002/ppul.22788 Maquet, 2009, Lethal respiratory failure and mild primary hypothyroidism in a term girl with a de novo heterozygous mutation in the TITF1/NKX2.1 gene, J. Clin. Endocrinol. Metab., 94, 197, 10.1210/jc.2008-1402 Glik, 2008, Psychosis, short stature in benign hereditary chorea: a novel thyroid transcription factor-1 mutation, Mov. Disord., 23, 1744, 10.1002/mds.22215 Krude, 2002, Choreoathetosis, hypothyroidism, and pulmonary alterations due to human NKX2-1 haploinsufficiency, J. Clin. Invest, 109, 475, 10.1172/JCI0214341 Iwatani, 2000, Deletion of NKX2.1 gene encoding thyroid transcription factor-1 in two siblings with hypothyroidism and respiratory failure, J. Pediatr., 137, 272, 10.1067/mpd.2000.107111 Kleinlein, 2011, Fatal neonatal respiratory failure in an infant with congenital hypothyroidism due to haploinsufficiency of the NKX2-1 gene: alteration of pulmonary surfactant homeostasis, Arch. Dis. Child. Fetal Neonatal Ed., 96, F453, 10.1136/adc.2009.180448 Thouvenin, 2010, Characteristics of disorders associated with genetic mutations of surfactant protein C, Arch. Dis. Child., 95, 449, 10.1136/adc.2009.171553 Devriendt, 1998, Deletion of thyroid transcription factor-1 gene in an infant with neonatal thyroid dysfunction and respiratory failure, N. Engl. J. Med., 338, 1317, 10.1056/NEJM199804303381817 Gentile, 2016, 14q13 distal microdeletion encompassing NKX2-1 and PAX9: patient report and refinement of the associated phenotype, Am. J. Med. Genet. A, 170, 1884, 10.1002/ajmg.a.37691 Devos, 2006, New syndromic form of benign hereditary chorea is associated with a deletion of TITF-1 and PAX-9 contiguous genes, Mov. Disord., 21, 2237, 10.1002/mds.21135 Clement, 2010, Interstitial lung diseases in children, Orphanet J. Rare Dis., 5, 22, 10.1186/1750-1172-5-22 Travis, 2013, An official American Thoracic Society/European Respiratory Society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias, Am. J. Respir. Crit. Care Med., 188, 733, 10.1164/rccm.201308-1483ST Kurland, 2013, An official American Thoracic Society clinical practice guideline: classification, evaluation, and management of childhood interstitial lung disease in infancy, Am. J. Respir. Crit. Care Med., 188, 376, 10.1164/rccm.201305-0923ST Cottin, 2011, Combined pulmonary fibrosis and emphysema syndrome associated with familial SFTPC mutation, Thorax, 66, 918, 10.1136/thx.2010.151407 Mechri, 2010, Surfactant protein C gene (SFTPC) mutation-associated lung disease: high-resolution computed tomography (HRCT) findings and its relation to histological analysis, Pediatr. Pulmonol., 45, 1021, 10.1002/ppul.21289 Clement, 2004, Task force on chronic interstitial lung disease in immunocompetent children, Eur. Respir. J., 24, 686, 10.1183/09031936.04.00089803 Kolb, 2014, Staging of idiopathic pulmonary fibrosis: past, present and future, Eur. Respir. Rev., 23, 220, 10.1183/09059180.00002114 Deterding, 2010, Infants and young children with Children's interstitial lung disease, Pediatr. Allergy Immunol. Pulmonol., 23, 25, 10.1089/ped.2010.0011 Bolt, 2001, Glucocorticoids and lung development in the fetus and preterm infant, Pediatr. Pulmonol., 32, 76, 10.1002/ppul.1092 Knyazhitskiy, 2008, Beneficial response to macrolide antibiotic in a patient with desquamative interstitial pneumonia refractory to corticosteroid therapy, Chest, 134, 185, 10.1378/chest.07-2786 Thouvenin, 2013, Diffuse parenchymal lung disease caused by surfactant deficiency: dramatic improvement by azithromycin, BMJ Case Rep., 2013, 10.1136/bcr-2013-009988 Hayes, 2012, ABCA3 transporter deficiency, Am. J. Respir. Crit. Care Med., 186, 807, 10.1164/ajrccm.186.8.807 Zarbock, 2012, The surfactant protein C mutation A116D alters cellular processing, stress tolerance, surfactant lipid composition, and immune cell activation, BMC Pulm. Med., 12, 15, 10.1186/1471-2466-12-15 Williamson, 2014, Ten-year follow up of hydroxychloroquine treatment for ABCA3 deficiency, Pediatr. Pulmonol., 49, 299, 10.1002/ppul.22811